“Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors ” (2023) The Review of Diabetic Studies, 5(2). Available at: https://diabeticstudies.org/index.php/RDS/article/view/287 (Accessed: 13 September 2025).